Pioneering research at McGill’s Goodman Cancer Research Centre gets boost
The 4th Goodman Cancer Research Gala has raised more than $2.1 million to fund foundational research, more effective diagnostic tools and the development of new treatments and therapies for cancer patients. The Gala was held on Sunday, June 5 in Montreal, bringing together more than 800 guests in support of McGill University’s Rosalind and Morris Goodman Cancer Research Centre.
The results of their study, published in the journal Movement Disorders, could also have a major impact on the quality of research on Parkinson’s disease.
What is Parkinson’s Disease?
Parkinson’s disease is a neurological condition related to the death of specific brain cells that produce dopamine, a chemical needed for brain cells to control muscular movement. In Parkinson’s disease, dopamine-producing cells stop functioning for reasons still unknown.
Powerful treatment improves patients’ lives and provides new insight into mechanisms of the disease
A new study by Multiple Sclerosis researchers at three leading Canadian centres addresses why bone marrow transplantation (BMT) has positive results in patients with particularly aggressive forms of MS. The transplantation treatment, which is performed as part of a clinical trial and carries potentially serious risks, virtually stops all new relapsing activity as observed upon clinical examination and brain MRI scans. The study reveals how th
Genes predict the brain’s reaction to smoking
Have you ever wondered why some people find it so much easier to stop smoking than others? New research shows that vulnerability to smoking addiction is shaped by our genes. A study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University shows that people with genetically fast nicotine metabolism have a significantly greater brain response to smoking cues than those with slow nicotine metabolism.